Results for "Aspen Pharmacare"

Aspen Pharmacare forecasts that African market sales of the diabetes and weight-loss drug Mounjaro will exceed $124 million by 2027.

The pharmaceutical company reported improved earnings and provided an optimistic outlook for fiscal year 2027 during its latest earnings call transcript.

South Africa’s largest pharmaceutical company is restructuring its operations and investing heavily in sterile production facilities to recover from recent operational setbacks and secure future growth.